The duration of symptoms before diagnosis (lag time) was 
The symptoms and signs of cancer in children are caused by the effect of tumour mass on surrounding normal structures, secretion by the malignancy of a substance that disturbs normal function, or bone marrow failure. As a result, the commonest presenting features are fever, headache, vomiting, pallor and fatigue, bone pain, limping, weight loss, bleeding and/or the presence of a mass. Unfortunately, many of these symptoms and signs commonly occur in less sinister childhood illnesses. Justifiably, a diagnosis of malignancy is often not immediately considered when a child first presents and investigations for more benign disorders are initiated. As a consequence, most children with cancer are symptomatic for a period of time before the diagnosis is made. This period has been termed the lag time.
To date, only three studies have examined factors that influence the lag time in childhood cancer. Pratt et al analysed the presenting symptoms in 109 cases of rhabdomyosarcoma. 2 Flores et al found that the lag time for brain tumours was significantly longer than that for nephroblastomas or acute leukaemia. 3 The most recent and complete study by Pollock et tIn those children with acute leukaemia.
tClinical staging in 64 children with solid tumours. The lag time for brain tumours was significantly longer than for acute leukaemia, the estimated ratio of lag time of brain tumours to acute leukaemia was 2-0 (95% CI of 1-5 to 2-8, p= <0-001), that is children with brain tumours were estimated to have twice the lag time of children with leukaemia. Bone tumour, lymphoma, and nephroblastoma were of a borderline significant difference when compared with acute leukaemia, with the former two having a longer lag time and nephroblastoma having a shorter lag time.
As both age and diagnostic group were shown by univariate analysis ofvariance to be predictive for lag time, these were put into a multiway analysis of variance. Both age, F(1,160)= 16-96, p<0*001 and diagnostic group, F(6,160)=4-41, p<O-OOl were individually significant and the interaction terms were not significant. Table 3 shows the comparison between the other diagnostic groups and acute leukaemia with adjustment for age. Diagnostic group remains predictive with this adjustment for age, with the ratio between brain tumour and leukaemia estimated to be 2-0 (95% CI of 1-4 to 2-7, p=<0-001).
Of the 65 children with acute leukaemia, 12 presented with a white cell count of >-50x 109/1. As shown in table 1, the mean lag time in this group was 3-9 weeks compared with 5-3 in the 53 children with a lower white cell count. This difference was not significant; the estimated ratio of lag times in those with a presenting white cell count of -50x 109/1 as compared with those with a count <50x 109/1 was 1-1 (95% CI of 0-6 to 1-4 and p=O-7).
Clinical staging systems are different for each solid tumour and some tumours, for example brain tumours, are not usually staged. However, an advanced stage is indicative of advanced disease in all diagnostic groups. In 64 children with a solid tumour clinical staging of disease at presentation was possible. The mean lag times for those diagnosed to be in stages I, II, III, IV, and V are shown in Table 4 shows the mean lag time in the diagnostic groups from the various studies. The mean lag time of rhabdomyosarcoma in our study is similar to that seen by Pratt et al. 2 Flores et al also found that brain tumours had the longest lag time.3 While the lag time for acute leukaemia and nephroblastoma are comparable in our study with that of Flores et al, they described a mean lag time for brain tumours of 26 weeks while in our study it was 13 weeks. On the other hand, Pollock et al found the lag time for brain tumours to be 9-4 weeks. 4 The longest lag time in their study was seen in children with bone tumours, mean lag time in those with osteosarcoma being 11 5 weeks and those with Ewing's sarcoma 20-8 weeks. The lag times in children with lymphoma (7-1 weeks in nonHodgkin's lymphoma and 14 weeks in Hodgkin's disease) and neuroblastoma are comparable.
Discussion
In this study, lag time was shown to be significantly correlated with the age at presentation and the actual diagnosis. Multiway analysis of variance showed that age and diagnosis are independently associated with lag time and after adjustment for age the diagnosis continues to have a statistically significant association with the lag time. These findings are in agreement with the one previous study which similarly analysed factors that affect lag time.3 In the UK and USA younger children are likely to be seen more often by a physician than older children or adolescents and this may tend to decrease the lag time. 4 Additionally, detection of symptomatic disease in older children is dependent greatly on self reporting and may be particularly unreliable for adolescents. Therefore increased parent and physician awareness of a child's condition may account for a shorter lag time in younger children.4 In addition, the presenting features are a result of the effect of malignant tissue on surrounding structures. In younger children, reduced organ volume may also lead to a more rapid progression of symptoms with shortening of the lag time. This study and the previous ones3 4are in agreement that the diagnostic group is predictive of the lag time. However, while in this analysis and that of Flores et al brain tumours had a longer lag time, 3 Pollock et al found bone tumours and in particular Ewing's tumour to have the most significantly prolonged lag timnes.4 Additionally, while the lag times in some of the diagnostic groups were similar, they were markedly different in others and this included the group with brain tumours.
Brain tumours vary from benign to extremely malignant. It may be argued therefore that the variation in lag time in the three studies reflects the differences in the brain tumour populations. Flores et al also found that site of the brain tumour, not the histological diagnosis, appeared to influence lag time. 3 In their series mean lag time in supratentorial (38%) and infratentorial (62%) tumours was 43-4 weeks and 10-8 weeks respectively. While no such information was available from Pollock et For a paediatric oncologist, the index of suspicion of cancer is very high. The opposite is true for the general physician. If anything, there may be a general reluctance to consider such a diagnosis as cancer carries with it the fear of death, is rare in childhood, and is an unfamiliar diagnosis for the non-specialist.9 It has been argued that increased vigilance on the part of the physician could lead to a shortening in the lag time.2" Logically, if the lag time is a function of delay in diagnosis rather than in the nature of the disease, a shorter lag time should improve prognosis. In this study we have been unable to find a positive correlation between length of lag time and outcome. This suggests that it is the nature and epidemiology of disease that are the important determinants for lag time. Therefore, we do not feel that the onus should be on the primary care physician to make an early diagnosis. Except in rare, individual cases3' it is more likely that the role of the general physician does not significantly affect lag time. Instead it is a subsidiary factor that contributes to the health care structure, itself a significant determinant.
This study has obvious limitations. The numbers in each diagnostic category are small. As analysis relied on retrospective review of medical records, it was not possible to assess the reliability with which the date of symptom onset was recorded. Nor has it been possible to analyse directly the role of physician, parent, or health care systems. However, the results of this study indicate that age at presentation and actual diagnosis are determinants for lag time, that there is a geographical variation in lag time in the diagnostic groups for which the most probable explanation is the variation in health support systems, and that lag time is not related to survival.
